Clinical Trial Update: An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon [Phase 1, Phase 2]

View source ↗

Summary

Terminated Phase 1/2 open-dose study evaluating oral hexaminolevulinate imaging in patients with suspected or high-risk colorectal neoplasia (colon cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Hexaminolevulinate (hexaminolevulinate)

Snippet

Sponsor: Photocure | Conditions: Colon Cancer | Phase 1, Phase 2 | Status: TERMINATED